It goes without saying that both specialised medical care and primary health care will gain from these R&D projects.
“We will ensure that HUS continues to ambitiously lead the way in healthcare. Our efficient research and development work helps to build knowledge-based services, digital treatment pathways and a more cost-effective and effective care. A wide European cooperation is of great benefit for both patients and society as a whole,” says Suzan Ikävalko, Head of EU Funding at HUS.
National funding has an important role
Although there is plenty of funding available, the competition for European funding is fierce. To receive EU funding, the consortia must truly be strong and have a solid research background that has been built largely with national funding. National funding helps to create a strong basis, which is needed and found behind the important success in EU funding calls. In recent years, HUS success rate in EU Consortium calls has been better than the Finnish average regarding applications for research and innovation projects in healthcare. Its investments in the prerequisites for research activities can be seen as a clear success factor.
The European Union provides funding for tackling healthcare challenges through various channels, both for individual research groups and for large-scale research and innovation projects. HUS Helsinki University Hospital has the world’s most advanced and largest public data lake for research use. This Data Pool and related analytics expertise are the strengths of HUS in the EU competition.
Active collaboration with various partners
An increasing number of chronic diseases and an ageing population is indeed putting a strain on specialised medical care, as well as on primary health care. Continuous development and research activities are needed for maintaining a high-quality and evidence-based care. Various ongoing research and innovation projects will create solutions for, among other things, sharing and utilising information, value-based healthcare, evaluating health care methods and keeping treatment recommendations up to date.
HUS Helsinki University Hospital collaborates actively with companies in R&I projects on data, analytics and AI also in the CleverHealth Network ecosystem. Research services (such as clinical studies, medical device testing, sponsored research) are offered via the HUS Testbed (medical devices) and the Clinical Research Institute HUCH (pharmaceuticals).
Read more about the Health ecosystem in the Helsinki Smart Region.’
The article was first published in Finnish on the website of HUS (longer version).